Heart failure is a common complication of obesity [61, 62], and clinical trials have shown that GLP-1 analogs, particularly tirzepatide, can improve cardiac function and reduce the risk of heart failure in people with obesity [63]
Any weight-related goal should be discussed with a licensed clinician, especially if other conditions or medicines affect safety
This product can be paired with any of our weight loss programs
This article explores the science behind the pairing, potential benefits for energy and metabolism, and how a personalized program can help you navigate these options safely
RISKS FOR HEALTHCARE PROVIDERS CREATED BY GLP-1S Even as its getting easier for patients to obtain GLP-1s, there is still a relatively small number of healthcare providers trained in obesity care
Prescribers should use their independent clinical judgment when determining appropriateness for individual patients.